Clinical trial
A Prospective, Randomized, Controlled Study to Evaluate the Impact of Remote Symptom Management Via Smartphone App Based on Electronic Patient-Reported Outcomes on Rehabilitation Exercise Adherence After Minimally Invasive Surgery in Lung Cancer Patients
NCT05990946 is registered in ClinicalTrials.gov with Zhongshan People's Hospital, Guangdong, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled Study to Evaluate the Impact of Remote Symptom Management Via Smartphone App Based on Electronic Patient-Reported Outcomes on Rehabilitation Exercise Adherence After Minimally Invasive Surgery in Lung Cancer Patients
- Lead sponsor
- Zhongshan People's Hospital, Guangdong, China
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 1, 2023
- Completion date
- June 30, 2027
- Enrollment
- 736 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
exercise therapy, lung neoplasms, non-small cell lung cancer, patient reported outcome measures, postoperative complications, telerehabilitation